Mitsubishi Electric Corporation

Dainippon Sumitomo Pharma Co., Ltd.

Sumitomo Dainippon Pharma Co., Ltd.

Sumitomo Pharma Co., Ltd.

Yuki Fujii

Andrew Simon Bell

Jeremy Besnard

Tomoyuki Furuta

Yoshinori Aihara

Keiji Adachi

Hideya Shibata

Yoko Nakai

Masashi Tatedoko

Masayuki Sakuma

The present invention relates to a compound represented by formula (1): the compound having antagonist activity against serotonin 5-HTreceptors and serotonin 5-HTreceptors; or a pharmaceutically acceptable salt of the compound. (In the formula, Z is a nitrogen atom and the like; Y is carbonyl and the like; m and n are 1 and the like; Rthrough R, Rthrough R, and Rthrough Rare a hydrogen atom and the like; Ris alkyl and the like; and Q is a specific bicyclic group.)

Aliphatic acid amide derivative

In a job management apparatus, a reception part receives an input of definition information that defines a running sequence and a running condition of a plurality of job steps. If an abnormal end occurs in a job step included in a job run by the apparatus in accordance with the definition information, the apparatus runs a retry job including a restarting step, which is the job step in which the abnormal end has occurred, and a job step posterior to the restarting step in the running sequence defined by the definition information and satisfying the running condition defined by the definition information at the occurrence of the abnormal end in the restarting step. The apparatus stops running the restarting step and the job step posterior to the restarting step in the running sequence defined by the definition information at least until the run of the retry job is completed.

Job management apparatus, job management method and computer readable medium to generate and execute a retry job when an error occurs during a job step

The present invention provides a compound represented by the formula (1) or a pharmaceutically acceptable salt thereof (wherein W represents a hydrogen atom, a halogen atom, or the others; A represents an alkyl group optionally substituted by aryl group or the others, an aryl group, or the others; and one of X and Y represents a di-substituted alkylaminocarbonyl group, or the others, and the other represents a hydrogen atom, an alkyl group, an alkylcarbonyl group, or the others); a medicament or a pharmaceutical composition for treatment or prophylaxis of FAAH-related diseases such as depression, anxiety disorder or pains, comprising the compound or the like as an active ingredient; a use of the compound or the like; and a method for treatment or prophylaxis using the compound or the like. 

8-oxodihydropurine derivative

Growing community of inventors

Tokyo, Japan

Yuki Fujii